SCHEMBL21362664

SCHEMBL21362664

COc1cc(C(O)c2ccc(C)cc2Br)c(C)cc1F

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 1/20 0.37
RIN1 Q13671 1/20 0.37
L3MBTL1 Q9Y468 6/20 0.35
MAPT P10636 5/20 0.35
HPGD P15428 3/20 0.35
TDP1 Q9NUW8 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
MEN1 O00255 1/20 0.34
POLB P06746 1/20 0.34
KMT2A Q03164 1/20 0.34
ACHE P22303 1/20 0.34
LMNA P02545 1/20 0.34
MAPK1 P28482 1/20 0.34
KDM4E B2RXH2 1/20 0.34
CYP1A2 P05177 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
TUBB1 Q9H4B7 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20158035 0.87 ABL1 (0.36) ABL1RIN1L3MBTL1MAPTHPGD
SCHEMBL20157895 0.81 TOP2A (0.37) ABL1RIN1L3MBTL1MAPTHPGD
SCHEMBL20157992 0.81 TOP2A (0.40) ABL1RIN1L3MBTL1MAPTHPGD
SCHEMBL21352139 0.81 MAPT (0.40) ABL1RIN1L3MBTL1MAPTHPGD
SCHEMBL20158171 0.77 LMNA (0.41) ABL1RIN1L3MBTL1MAPTHPGD
SCHEMBL20157481 0.75 TOP2A (0.39) ABL1RIN1L3MBTL1MAPTHPGD
SCHEMBL21362749 0.73 TRPA1 (0.48) ABL1RIN1L3MBTL1MAPTHPGD
SCHEMBL20158027 0.73 ABL1 (0.48) ABL1RIN1L3MBTL1MAPTHPGD
SCHEMBL21564876 0.72 LMNA (0.34) L3MBTL1NPC1RAB9AMEN1KMT2A
SCHEMBL24826176 0.71 MGAM (0.40) RAB9ALMNAMAPK1CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3539960-A1 NITROGENOUS MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF Luoxin Pharmaceutical (Shanghai) Co., Ltd. (CN) 2019-09-18 EP disclosed